Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease

BACKGROUND: Copeptin and intact fibroblast growth factor 23 (iFGF23) increase early during chronic kidney disease (CKD) and may be predictive of unfavourable outcomes. The aim of this study was to evaluate their respective associations with renal and vital outcomes in CKD patients. METHODS: We inclu...

Descripción completa

Detalles Bibliográficos
Autores principales: Michon-Colin, Arthur, Metzger, Marie, Bankir, Lise, Gauci, Cédric, Brunel, Mélanie, Baron, Stéphanie, Prot-Bertoye, Caroline, Stengel, Bénédicte, Thervet, Eric, Haymann, Jean-Philippe, Boffa, Jean-Jacques, Vrtovsnik, François, Flamant, Martin, Houillier, Pascal, Prie, Dominique, Courbebaisse, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689138/
https://www.ncbi.nlm.nih.gov/pubmed/38046034
http://dx.doi.org/10.1093/ckj/sfad149

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689138/
https://www.ncbi.nlm.nih.gov/pubmed/38046034
http://dx.doi.org/10.1093/ckj/sfad149

Ejemplares similares